201-202
Editorial Commentary
Therapeutic nuclear medicine expands to breast cancer
Marc André Mahé, Albert Lisbona and Jean-François Chatal
203-211
Original Article
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin
Giovanni Paganelli, Concetta De Cicco, Mahila E. Ferrari, Giuseppe Carbone and Gianmatteo Pagani, et al.
212-225
Original Article
Individualized dosimetry in patients undergoing therapy with 177Lu-DOTA-D-Phe1-Tyr3-octreotate
Mattias Sandström, Ulrike Garske, Dan Granberg, Anders Sundin and Hans Lundqvist
226-234
Original Article
Open AccessAlbumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
Erik Vegt, Annemarie Eek, Wim J. G. Oyen, Marion de Jong and Martin Gotthardt, et al.
235-241
Original Article
Wild-type p53 enhances the cytotoxic effect of radionuclide gene therapy using sodium iodide symporter in a murine anaplastic thyroid cancer model
Yong Jin Lee, June-Key Chung, Joo Hyun Kang, Jae Min Jeong and Dong Soo Lee, et al.
242-249
Original Article
Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium
Daniele Barbaro, Mariano Grosso, Giuseppe Boni, Paola Lapi and Cristina Pasquini, et al.
250-259
Original Article
Open Accessp-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
Lars R. Perk, Maria J. W. D. Vosjan, Gerard W. M. Visser, Marianne Budde and Paul Jurek, et al.
260-269
Original Article
186Re-maSGS-ZHER2:342, a potential Affibody conjugate for systemic therapy of HER2-expressing tumours
Anna Orlova, Thuy A. Tran, Torun Ekblad, Amelie Eriksson Karlström and Vladimir Tolmachev
270-275
Original Article
A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer
Glenn D. Flux, Masud Haq, Sarah J. Chittenden, Susan Buckley and Cecilia Hindorf, et al.
276-283
Original Article
No survival difference after successful 131I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer
Frederik Anton Verburg, Marcel P. M. Stokkel, Christian Düren, Robbert B. T. Verkooijen and Uwe Mäder, et al.
284-300
Original Article
Meta-analysis of the performance of 18F-FDG PET in cutaneous melanoma
Felisa Jiménez-Requena, Roberto C. Delgado-Bolton, Cristina Fernández-Pérez, Sanjiv S. Gambhir and Judy Schwimmer, et al.
301-309
Original Article
Predictive factors of [11C]choline PET/CT in patients with biochemical failure after radical prostatectomy
Giampiero Giovacchini, Maria Picchio, Elisa Coradeschi, Valentino Bettinardi and Luigi Gianolli, et al.
310-318
Original Article
Potential impact of 68Ga-DOTATOC PET/CT on stereotactic radiotherapy planning of meningiomas
Fonyuy Nyuyki, Michail Plotkin, Reinhold Graf, Roger Michel and Ingo Steffen, et al.
319-329
Original Article
Role of PET/CT in malignant pediatric lymphoma
Raef Riad, Walid Omar, Magdy Kotb, Magdy Hafez and Iman Sidhom, et al.
330-338
Original Article
Radiobiological effects of hypoxia-dependent uptake of 64Cu-ATSM: enhanced DNA damage and cytotoxicity in hypoxic cells
Amanda J. Weeks, Rowena L. Paul, Paul K. Marsden, Philip J. Blower and Daniel R. Lloyd
339-348
Original Article
Detection of hypoxia in microscopic tumors using 131I-labeled iodo-azomycin galactopyranoside (131I-IAZGP) digital autoradiography
Xiao-Feng Li, Xiaorong Sun, Yuanyuan Ma, Makiko Suehiro and Mutian Zhang, et al.
349-356
Original Article
Assessment of poststress left ventricular ejection fraction by gated SPECT: comparison with equilibrium radionuclide angiocardiography
Wanda Acampa, Maria Grazia Caprio, Emanuele Nicolai, Raffaele Liuzzi and Serena De Luca, et al.
357-367
Original Article
Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes
Cecilia Marini, GianPaolo Bezante, Patrizia Gandolfo, Elisa Modonesi and Silvia D. Morbelli, et al.
368-376
Original Article
Impaired myocardial blood flow reserve in subjects with metabolic syndrome analyzed using positron emission tomography and N-13 labeled ammonia
Hiroki Teragawa, Koichi Morita, Hiroki Shishido, Nobuaki Otsuka and Yutaka Hirokawa, et al.
377-385
Original Article
Quantification of regional myocardial oxygen metabolism in normal pigs using positron emission tomography with injectable 15O-O2
Takashi Temma, Hidehiro Iida, Takuya Hayashi, Noboru Teramoto and Youichiro Ohta, et al.
386-398
Review Article
Open AccessMolecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies
G. Malviya, F. Conti, M. Chianelli, F. Scopinaro and R. A. Dierckx, et al.
399-404
Focus on
Molecular imaging in cognitive impairment: the relevance of cognitive reserve, importance of multisite longitudinal trials and challenges of standardised analysis
Giovanni Lucignani and Robert Perneczky
405-406
Book Review
Bluth EI, Benson CB, Ralls PW, Siegel MJ (eds): Ultrasonography in vascular diseases. A practical approach to clinical problems (2nd edition)
Thieme Publishing Group, New York 2007, ISBN 978-3-13-129142-4
Gianfranco Vallone and Massimo Vallone
407-408
Letter to the Editor
PET/CT for the assessment and quantification of 90Y biodistribution after selective internal radiotherapy (SIRT) of liver metastases
Matthias K. Werner, Klaus Brechtel, Thomas Beyer, Helmut Dittmann and Christina Pfannenberg, et al.
409
Image of the Month
Unsuspected hibernating myocardium detected by routine oncology 18F-FDG PET/CT
Didier Vilain, Jean Bochet, Elise Le Stanc, Clement Wattel and Amine Hameg, et al.
410
Image of the Month
Symmetrical nail bed uptake on a 99mTc-HDP bone scan in a patient with Wegener’s granulomatosis
Danijela Dejanović, Alice Widding Høyer, Jann Mortensen and Liselotte Højgaard
411-419
Society Communications
EANM’09 Barcelona–a congress to be remembered!
420-429
Society communications
Certificate of Fellowship of the European Board of Nuclear Medicine 2010 Information
430-433
Society Communications
Syllabus for postgraduate specialisation in Nuclear Medicine
2006/07 update
Alberto Cuocolo, Metka Milčinski and Angelika Bischof Delaloye
434-442
Guidelines
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
Koen Van Laere, Andrea Varrone, Jan Booij, Thierry Vander Borght and Flavio Nobili, et al.
443-450
Guidelines
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
Jacques Darcourt, Jan Booij, Klaus Tatsch, Andrea Varrone and Thierry Vander Borght, et al.